EP1060748A4 - MEDICATIONS FOR CORNEAL EPITHELIUM DISORDERS - Google Patents

MEDICATIONS FOR CORNEAL EPITHELIUM DISORDERS

Info

Publication number
EP1060748A4
EP1060748A4 EP99906472A EP99906472A EP1060748A4 EP 1060748 A4 EP1060748 A4 EP 1060748A4 EP 99906472 A EP99906472 A EP 99906472A EP 99906472 A EP99906472 A EP 99906472A EP 1060748 A4 EP1060748 A4 EP 1060748A4
Authority
EP
European Patent Office
Prior art keywords
medications
corneal epithelium
epithelium disorders
disorders
corneal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99906472A
Other languages
German (de)
French (fr)
Other versions
EP1060748A1 (en
Inventor
Ryoki Takahashi
Takayasu Noguchi
Kiyoshi Akiba
Takeo Omura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakamoto Pharmaceutical Co Ltd
Original Assignee
Wakamoto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakamoto Pharmaceutical Co Ltd filed Critical Wakamoto Pharmaceutical Co Ltd
Publication of EP1060748A1 publication Critical patent/EP1060748A1/en
Publication of EP1060748A4 publication Critical patent/EP1060748A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP99906472A 1998-02-25 1999-02-25 MEDICATIONS FOR CORNEAL EPITHELIUM DISORDERS Withdrawn EP1060748A4 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
JP5906398 1998-02-25
JP5906398 1998-02-25
JP14150098 1998-05-22
JP14150098 1998-05-22
JP18480198 1998-06-30
JP18480198 1998-06-30
JP28806398 1998-10-09
JP28806398 1998-10-09
PCT/JP1999/000853 WO1999043347A1 (en) 1998-02-25 1999-02-25 Remedies for corneal epithelium disturbance

Publications (2)

Publication Number Publication Date
EP1060748A1 EP1060748A1 (en) 2000-12-20
EP1060748A4 true EP1060748A4 (en) 2002-09-04

Family

ID=27463721

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99906472A Withdrawn EP1060748A4 (en) 1998-02-25 1999-02-25 MEDICATIONS FOR CORNEAL EPITHELIUM DISORDERS

Country Status (7)

Country Link
EP (1) EP1060748A4 (en)
KR (1) KR20010041337A (en)
CN (1) CN1291898A (en)
AU (1) AU752950B2 (en)
CA (1) CA2321704A1 (en)
TW (1) TW443931B (en)
WO (1) WO1999043347A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1305306B1 (en) * 1999-03-17 2001-05-04 Farmigea Spa USE OF PYRENOXIN FOR THE PROTECTION OF CORNEAL TISSUES IN INTERVENTION OF PHOTOCHERATECTOMY.
WO2001074393A1 (en) * 2000-04-04 2001-10-11 Wakamoto Pharmaceutical Co., Ltd. Vital tissue-protecting agents
WO2001091779A1 (en) * 2000-05-29 2001-12-06 Wakamoto Pharmaceutical Co., Ltd. Remedies for corneal injuries
JP5147156B2 (en) * 2003-08-08 2013-02-20 ロート製薬株式会社 Corneal disorder inhibitor
US20050202097A1 (en) * 2004-03-12 2005-09-15 Melbj Holdings, Llc, Florida Lubricant for the ocular surface
JP2007133001A (en) * 2005-11-08 2007-05-31 Seed Co Ltd Contact lens care products
JP2014098030A (en) * 2006-01-13 2014-05-29 Taisho Pharmaceutical Co Ltd Aqueous ophthalmic solution for preventing or ameliorating evaporation promotion-type dry eye
WO2009088119A1 (en) * 2008-01-07 2009-07-16 Bioleaders Corporation Composition for preventing or treating dry eye syndrome comprising poly-gamma-glutamic acid
JP2010189442A (en) * 2010-06-07 2010-09-02 Rohto Pharmaceut Co Ltd Suppressor for corneal disorder
CN105592861A (en) * 2013-08-02 2016-05-18 赛诺菲 Use of anti-muc1 maytansinoid immunoconjugate antibody for the treatment of solid tumors
CN105999235A (en) * 2016-07-19 2016-10-12 上海建华精细生物制品有限公司 Extracellular matrix imitated eye drops and preparation method thereof
JP7598699B2 (en) * 2017-06-01 2024-12-12 ロート製薬株式会社 Ophthalmic composition for reactivating visual function
CA3174478A1 (en) 2020-03-05 2021-09-10 DiaMedica USA Inc. Ulinastatin polypeptides
CN119732946A (en) * 2025-02-18 2025-04-01 江西中医药大学 Application of scutellaria lactone in preparing medicine for treating dry eye

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI854634A0 (en) * 1985-11-22 1985-11-22 Labsystems Oy FOERFARANDE FOER BESTAEMNING AV PROTEOLYTISK AKTIVITET.
JP2547325B2 (en) * 1987-04-24 1996-10-23 持田製薬株式会社 Topical for the treatment of allergic diseases

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
OHNISHI H ET AL: "PHARMACOLOGICAL ACTIVITIES OF A TRYPSIN INHIBITOR, URINASTATIN (MIRACLID )", OYO YAKURI - PHARMACOMETRICS, XX, XX, vol. 31, no. 3, 1986, pages 663 - 675, XP000881560, ISSN: 0300-8533 *
See also references of WO9943347A1 *

Also Published As

Publication number Publication date
AU752950B2 (en) 2002-10-03
CA2321704A1 (en) 1999-09-02
AU2639799A (en) 1999-09-15
WO1999043347A1 (en) 1999-09-02
EP1060748A1 (en) 2000-12-20
TW443931B (en) 2001-07-01
CN1291898A (en) 2001-04-18
KR20010041337A (en) 2001-05-15

Similar Documents

Publication Publication Date Title
EP0788359A4 (en) COMPOSITIONS USEFUL IN THE PREPARATION OF MEDICINES FOR THE TREATMENT OF VARIOUS REFRACTORY DISORDERS
AU5945296A (en) Medicament for nasal administration
EP1060748A4 (en) MEDICATIONS FOR CORNEAL EPITHELIUM DISORDERS
AU1407399A (en) Treatment for alzheimer's disease
DZ1876A1 (en) Medicines for oral administration.
IL138093A0 (en) Pharmaceuticals for the imaging of angiogenic disorders
NZ297342A (en) Thiadiazolidin-3-one 1,1-dioxides; medicaments
IL119417A0 (en) Drug for Parkinson's disease
AU2639299A (en) Remedies/preventives for parkinson's disease
AUPP370298A0 (en) A device for preventing or reducing the passage of air through a wearer's mouth
AU5800896A (en) Non-steroidal anti-inflammatory drugs for the cyto-protection of the trabecular meshwork
EP0791358A4 (en) Remedy for ophthalmic diseases
AU5053296A (en) Pharmaceutical agents for the treatment of Alzheimer's disease
AU1405899A (en) Treatment for alzheimer's disease
FR2716623B1 (en) Use of a tricyclic derivative for obtaining medicaments intended for the treatment of mnemo-cognitive disorders.
MXPA01003761A (en) Remedies for ocular diseases.
CA2260863A1 (en) Treatment of psychotic disorders
AU7449698A (en) Therapeutic agents for respiratory diseases
AU7847198A (en) Therapeutic antioxidants for alzheimer's disease
AU8883998A (en) Pharmaceutical compositions for the treatment of ocular inflammations comprisingdexamethasone palmitate
AU7726796A (en) Use of 3-oxa-d-prostaglandins for the manufacture of a medicament for the treatment of glaucoma
EP0774260A4 (en) Remedy for corneal diseases
EP1142585A4 (en) Remedies for corneal disorders
EP1053748A4 (en) Remedies for neurological disorders
AU3444299A (en) Pharmaceutical composition for oral administration having therapeutic activity on gastrointestinal disorders

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000831

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020722

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 38/57 A, 7A 61P 27/02 B

17Q First examination report despatched

Effective date: 20021118

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030329